219 related articles for article (PubMed ID: 25257237)
1. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty.
Duncan CM; Gillette BP; Jacob AK; Sierra RJ; Sanchez-Sotelo J; Smith HM
J Arthroplasty; 2015 Feb; 30(2):272-6. PubMed ID: 25257237
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic Acid Was Safe in Arthroplasty Patients With a History of Venous Thromboembolism: A Matched Outcome Study.
Sabbag OD; Abdel MP; Amundson AW; Larson DR; Pagnano MW
J Arthroplasty; 2017 Sep; 32(9S):S246-S250. PubMed ID: 28262452
[TBL] [Abstract][Full Text] [Related]
3. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
4. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties.
Ido K; Neo M; Asada Y; Kondo K; Morita T; Sakamoto T; Hayashi R; Kuriyama S
Arch Orthop Trauma Surg; 2000; 120(9):518-20. PubMed ID: 11011672
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion and venous thromboembolism trends and risk factors in primary and aseptic revision total hip and knee arthroplasties: A nationwide investigation of 736,061 cases.
Jeschke E; Citak M; Halder AM; Heller KD; Niethard FU; Schräder P; Zacher J; Leicht H; Malzahn J; Günster C; Gehrke T
Orthop Traumatol Surg Res; 2022 Feb; 108(1):102987. PubMed ID: 34144253
[TBL] [Abstract][Full Text] [Related]
6. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty.
Madsen RV; Nielsen CS; Kallemose T; Husted H; Troelsen A
J Arthroplasty; 2017 Apr; 32(4):1298-1303. PubMed ID: 27843042
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic Acid in Hip and Knee Arthroplasty.
Melvin JS; Stryker LS; Sierra RJ
J Am Acad Orthop Surg; 2015 Dec; 23(12):732-40. PubMed ID: 26493971
[TBL] [Abstract][Full Text] [Related]
8. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.
Evangelista PJ; Aversano MW; Koli E; Hutzler L; Inneh I; Bosco J; Iorio R
Orthop Clin North Am; 2017 Apr; 48(2):109-115. PubMed ID: 28336035
[TBL] [Abstract][Full Text] [Related]
10. Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases.
Xie J; Ma J; Kang P; Zhou Z; Shen B; Yang J; Pei F
Thromb Res; 2015 Aug; 136(2):234-8. PubMed ID: 26026635
[TBL] [Abstract][Full Text] [Related]
11. The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.
Hallstrom B; Singal B; Cowen ME; Roberts KC; Hughes RE
J Bone Joint Surg Am; 2016 Oct; 98(19):1646-1655. PubMed ID: 27707851
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid in patients with current or former cancer undergoing hip and knee arthroplasty.
Varady NH; Chen AF; Drayer NJ; Ready J; Lozano-Calderon SA; Hayden BL
J Surg Oncol; 2021 May; 123(8):1811-1820. PubMed ID: 33713439
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic Acid Reduces Blood Transfusions in Revision Total Hip Arthroplasty.
Park KJ; Couch CG; Edwards PK; Siegel ER; Mears SC; Barnes CL
J Arthroplasty; 2016 Dec; 31(12):2850-2855.e1. PubMed ID: 27426220
[TBL] [Abstract][Full Text] [Related]
15. The Use of Intravenous Tranexamic Acid in Patients Undergoing Total Hip or Knee Arthroplasty: A Retrospective Analysis at a Single Military Institution.
Formby PM; Pickett AM; Van Blarcum GS; Mack AW; Newman MT
Mil Med; 2015 Oct; 180(10):1087-90. PubMed ID: 26444472
[TBL] [Abstract][Full Text] [Related]
16. Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.
DiBlasi JF; Smith RP; Garavaglia J; Quedado J; Frye BM; Dietz MJ
Am J Orthop (Belle Mead NJ); 2016; 45(7):E439-E443. PubMed ID: 28005108
[TBL] [Abstract][Full Text] [Related]
17. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
Kopanidis P; Hardidge A; McNicol L; Tay S; McCall P; Weinberg L
J Orthop Surg Res; 2016 Feb; 11():28. PubMed ID: 26927608
[TBL] [Abstract][Full Text] [Related]
18. Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.
Kim YH; Park JW; Kim JS
J Arthroplasty; 2017 Feb; 32(2):641-644. PubMed ID: 27614816
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
20. Occult Left Common Iliac Vein Compression Increases Postoperative Venous Thromboembolism Risk Following Total Hip Arthroplasty.
Bergen MA; Wall KC; Kim CY; Garrigues GE
J Arthroplasty; 2019 Feb; 34(2):375-378. PubMed ID: 30448323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
